Legal & General Group
CINC

Legal & General Group’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Legal & General Group’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,919
Closed -$85K – 3414
2022
Q4 		$85K Buy
6,919
+810
+13% +$19.3K ﹤0.01% 2851
2022
Q3 		$200K Buy
6,109
+1,775
+41% +$50.2K ﹤0.01% 2629
2022
Q2 		$81K Buy
4,334
+3,231
+293% +$61.9K ﹤0.01% 2907
2022
Q1 		$19K Buy
+1,103
New +$22.6K ﹤0.01% 3257

Legal & General Group's CINC Position: Q1 2023 in Review

Legal & General Group sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 6,919 shares — an estimated $85K sold.

Legal & General Group first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $200K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Legal & General Group reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Legal & General Group sold 6,919 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $85K.
  • Legal & General Group first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Legal & General Group's CinCor Pharma, Inc. Common Stock position peaked at $200K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Legal & General Group's 13F filing for Q1 2023, filed 15 May 2023.